Persistent URL of this record https://hdl.handle.net/1887/3458844
Documents
-
- Download
- 1-s2.0-S0959804921012648-main
- Publisher's Version
-
open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
UGT1A1 genotype-guided dosing of irinotecan: a prospective safety and cost analysis in poor metaboliser patients
- All authors
- Hulshof, E.C.; With, M. de; Man, F.M. de; Creemers, G.J.; Deiman, B.A.L.M.; Swen, J.J.; Houterman, S.; Koolen, S.L.W.; Bins, S.; Thijs, A.M.J.; Laven, M.M.J.; Hovels, A.M.; Luelmo, S.A.C.; Houtsma, D.; Shulman, K.; McLeod, H.L.; Schaik, R.H.N. van; Guchelaar, H.J.; Mathijssen, R.H.J.; Gelderblom, H.; Deenen, M.J.
- Date
- 2022-02-01
- Journal
- European Journal of Cancer
- Volume
- 162
- Pages
- 148 - 157